Avalyn Pharma

AVLNNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.504 B

$33.92 +3.73%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

44,333,095

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#137XencorXNCR$1.55B
#138HarrowHROW$1.51B
#139Avalyn PharmaAVLN$1.50B
#140InnovivaINVA$1.48B
#141ArriVent BioPharmaAVBP$1.44B

Where these numbers come from

Share counts and financials for Avalyn Pharma are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.